Literature DB >> 24095922

Myoglobin overexpression inhibits reperfusion in the ischemic mouse hindlimb through impaired angiogenesis but not arteriogenesis.

Joshua K Meisner1, Ji Song1, Brian H Annex2, Richard J Price3.   

Abstract

Adaptive vascular remodeling in response to arterial occlusion takes the form of capillary growth (angiogenesis) and outward remodeling of pre-existing collateral arteries (arteriogenesis). However, the relative contributions of angiogenesis and arteriogenesis toward the overall reperfusion response are both highly debated and poorly understood. Here, we tested the hypothesis that myoglobin overexpressing transgenic mice (MbTg(+)) exhibit impaired angiogenesis in the setting of normal arteriogenesis in response to femoral artery ligation, and thereby serve as a model for disconnecting these two vascular growth processes. After femoral artery ligation, MbTg(+) mice were characterized by delayed distal limb reperfusion (by laser Doppler perfusion imaging), decreased foot use, and impaired distal limb muscle angiogenesis in both glycolytic and oxidative muscle fiber regions at day 7. Substantial arteriogenesis occurred in the primary collaterals supplying the ischemic limb in both wild-type and MbTg(+) mice; however, there were no significant differences between groups, indicating that myoglobin overexpression does not affect arteriogenesis. Together, these results uniquely demonstrate that functional collateral arteriogenesis alone is not necessarily sufficient for adequate reperfusion after arterial occlusion. Angiogenesis is a key component of an effective reperfusion response, and clinical strategies that target both angiogenesis and arteriogenesis could yield the most efficacious treatments for peripheral arterial disease.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24095922      PMCID: PMC5746951          DOI: 10.1016/j.ajpath.2013.08.005

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  National health care costs of peripheral arterial disease in the Medicare population.

Authors:  Alan T Hirsch; Lacey Hartman; Robert J Town; Beth A Virnig
Journal:  Vasc Med       Date:  2008-08       Impact factor: 3.239

Review 3.  Fiber types in mammalian skeletal muscles.

Authors:  Stefano Schiaffino; Carlo Reggiani
Journal:  Physiol Rev       Date:  2011-10       Impact factor: 37.312

Review 4.  Marvels, mysteries, and misconceptions of vascular compensation to peripheral artery occlusion.

Authors:  Matthew A Ziegler; Matthew R Distasi; Randall G Bills; Steven J Miller; Mouhamad Alloosh; Michael P Murphy; A George Akingba; Michael Sturek; Michael C Dalsing; Joseph L Unthank
Journal:  Microcirculation       Date:  2010-01       Impact factor: 2.628

Review 5.  Stimulation of collateral artery growth: travelling further down the road to clinical application.

Authors:  S H Schirmer; F C van Nooijen; J J Piek; N van Royen
Journal:  Heart       Date:  2009-03       Impact factor: 5.994

6.  Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.

Authors:  Sanjay Rajagopalan; Emile R Mohler; Robert J Lederman; Farrell O Mendelsohn; Jorge F Saucedo; Corey K Goldman; John Blebea; Jennifer Macko; Paul D Kessler; Henrik S Rasmussen; Brian H Annex
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

7.  Arteriogenesis proceeds via ICAM-1/Mac-1- mediated mechanisms.

Authors:  Imo E Hoefer; Niels van Royen; John E Rectenwald; Elisabeth Deindl; Jing Hua; Marco Jost; Sebastian Grundmann; Michiel Voskuil; C Keith Ozaki; Jan J Piek; Ivo R Buschmann
Journal:  Circ Res       Date:  2004-04-01       Impact factor: 17.367

8.  Ultrasonic microbubble destruction stimulates therapeutic arteriogenesis via the CD18-dependent recruitment of bone marrow-derived cells.

Authors:  John C Chappell; Ji Song; Alexander L Klibanov; Richard J Price
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04-10       Impact factor: 8.311

9.  Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.

Authors:  M Ziche; L Morbidelli; E Masini; S Amerini; H J Granger; C A Maggi; P Geppetti; F Ledda
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2.

Authors:  D D Thomas; X Liu; S P Kantrow; J R Lancaster
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  14 in total

1.  Epigenetic regulators of the revascularization response to chronic arterial occlusion.

Authors:  Joshua L Heuslein; Catherine M Gorick; Richard J Price
Journal:  Cardiovasc Res       Date:  2019-03-15       Impact factor: 10.787

2.  Computational Network Model Prediction of Hemodynamic Alterations Due to Arteriolar Rarefaction and Estimation of Skeletal Muscle Perfusion in Peripheral Arterial Disease.

Authors:  Joshua L Heuslein; Xuanyue Li; Kelsey P Murrell; Brian H Annex; Shayn M Peirce; Richard J Price
Journal:  Microcirculation       Date:  2015-07       Impact factor: 2.628

3.  Despite normal arteriogenic and angiogenic responses, hind limb perfusion recovery and necrotic and fibroadipose tissue clearance are impaired in matrix metalloproteinase 9-deficient mice.

Authors:  Joshua K Meisner; Brian H Annex; Richard J Price
Journal:  J Vasc Surg       Date:  2014-02-28       Impact factor: 4.268

4.  The partitioning of nanoparticles to endothelium or interstitium during ultrasound-microbubble-targeted delivery depends on peak-negative pressure.

Authors:  Y-H Hsiang; J Song; R J Price
Journal:  J Nanopart Res       Date:  2015-08-22       Impact factor: 2.253

5.  PADPIN: protein-protein interaction networks of angiogenesis, arteriogenesis, and inflammation in peripheral arterial disease.

Authors:  Liang-Hui Chu; Chaitanya G Vijay; Brian H Annex; Joel S Bader; Aleksander S Popel
Journal:  Physiol Genomics       Date:  2015-06-09       Impact factor: 3.107

6.  Vascular growth responses to chronic arterial occlusion are unaffected by myeloid specific focal adhesion kinase (FAK) deletion.

Authors:  Joshua L Heuslein; Kelsey P Murrell; Ryan J Leiphart; Ryan A Llewellyn; Joshua K Meisner; Richard J Price
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

7.  MicroRNA-146a Regulates Perfusion Recovery in Response to Arterial Occlusion via Arteriogenesis.

Authors:  Joshua L Heuslein; Stephanie P McDonnell; Ji Song; Brian H Annex; Richard J Price
Journal:  Front Bioeng Biotechnol       Date:  2018-01-22

Review 8.  The roles of interleukins in perfusion recovery after peripheral arterial disease.

Authors:  Lingdan Chen; Hanwei Liu; Mingjie Yuan; Wenju Lu; Jian Wang; Tao Wang
Journal:  Biosci Rep       Date:  2018-02-13       Impact factor: 3.840

9.  Hydrogen molecules (H2) improve perfusion recovery via antioxidant effects in experimental peripheral arterial disease.

Authors:  Jinrong Fu; Jinjing Zou; Cheng Chen; Hongying Li; Lei Wang; Yanli Zhou
Journal:  Mol Med Rep       Date:  2018-10-10       Impact factor: 2.952

10.  DNA Methyltransferase 1-Dependent DNA Hypermethylation Constrains Arteriogenesis by Augmenting Shear Stress Set Point.

Authors:  Joshua L Heuslein; Catherine M Gorick; Ji Song; Richard J Price
Journal:  J Am Heart Assoc       Date:  2017-11-30       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.